Drugmakers scramble to make Trump-friendly announcements ahead of deadline

What's new in pharma

September 26, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Days before Trump deadline to lower prices, companies push a flurry of initiatives. Will it be enough? The industry hopes that a flurry of new offerings and investments will help it avoid policies that threaten its interests. By Elaine Chen and Daniel Payne Opinion: Making health care more accountable and affordable through crowdsourcing To detect and deter waste, fraud, and abuse, HHS should make deidentified data on publicly funded health programs widely available By Ge Bai and David A. Hyman STAT+ | Trump threatens 100% tariffs on prescription drugs — unless companies build in the U.S. The president levied a major threat against pharmaceutical companies, days before a deadline he set for them to lower their drugs' prices. By Daniel Payne Adobe STAT+ | Federal judge vacates rule that would have ramped up Medicare Advantage audits A federal judge vacated a Biden-era rule that would have allowed the government to intensify its audits of private Medicare plans. By Tara Bannow

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser